PMV Pharmaceuticals Insider Trades
NASDAQ: PMVPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 1 · $1.52M
- Shares bought / sold
- 0 / 1.00M
- Net activity
- Net selling $1.5 million
PMV Pharmaceuticals insider activity
Over the last 12 months, PMV Pharmaceuticals insiders reported 2 transactions on SEC Form 4: 0 open-market purchases and 1 sale. Insiders bought $0 and sold $1.5 million worth of stock, for net insider selling of $1.5 million. The largest seller was ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC, with $1.5 million in reported sales.
The most recent filing shows Mack David Henry (President and CEO) reporting a transaction in 220,643 shares at $1.37 on Oct 27, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PMVP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PMVP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 27, 2025 | Mack David HenryPresident and CEO | Option exercise | 220,643 | $302.28K | Form 4 |
| Oct 23, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC10% Owner | Sale | 1,000,000 | $1.52M | Form 4 |
| Sep 10, 2025 | ORBIMED ADVISORS LLC & OrbiMed Capital GP V LLC10% Owner | Sale | 500,000 | $900.00K | Form 4 |
| Jul 1, 2025 | Jalota DeepikaChief Development Officer | Sale | 33,065 | $35.20K | Form 4 |
| Jul 1, 2025 | Carulli MichaelChief Financial Officer | Sale | 28,249 | $30.08K | Form 4 |
| Jul 1, 2025 | Ticktin RobertGeneral Counsel & COO | Sale | 23,151 | $24.65K | Form 4 |
| Jul 1, 2025 | Mack David HenryPresident and CEO | Sale | 58,411 | $62.18K | Form 4 |
| Jan 3, 2025 | Mack David HenryPresident and CEO | Option exercise | 17,709 | $9.39K | Form 4 |
| Dec 3, 2024 | Mack David HenryPresident and CEO | Option exercise | 91,750 | $48.63K | Form 4 |
| Sep 11, 2024 | Carulli MichaelChief Financial Officer | Sale | 2,891 | $4.35K | Form 4 |
| Sep 11, 2024 | Jalota DeepikaChief Development Officer | Sale | 7,218 | $10.85K | Form 4 |
| Jan 18, 2024 | Carulli MichaelChief Financial Officer | Award | 82,220 | — | Form 4 |
| Jan 18, 2024 | Jalota DeepikaChief Development Officer | Award | 95,555 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4